skip to content

Understand the whole picture

Vivitrol: Questions About Extended-Release Naltrexone

Vivitrol is an extended-release injectable form of naltrexone. It is used in specific circumstances for alcohol dependence and for prevention of relapse to opioid dependence after detoxification. It works differently from buprenorphine, and the assessment before treatment is especially important.

Vivitrol: Questions About Extended-Release Naltrexone

An opioid antagonist, with two distinct uses

Naltrexone is an opioid antagonist: it blocks opioid receptors rather than acting as an opioid agonist. Vivitrol is an injection administered by a healthcare professional. Oral naltrexone and extended-release naltrexone are different formulations; the choice and approved use should be discussed with the prescriber.

The Vivitrol prescribing information distinguishes treatment of alcohol dependence in appropriately selected patients from prevention of relapse to opioid dependence following detoxification. For either reason, the injection is part of a broader care plan. It does not replace an assessment of withdrawal, mental health, pain needs, and the support required between appointments.

What must be assessed before the first injection

A clinician must establish whether you can safely receive naltrexone. Recent opioid exposure is particularly important because giving it when opioids are still affecting the body can trigger severe withdrawal. Tell the team about prescription pain medicines, nonprescribed opioids, buprenorphine, methadone, and any uncertain exposure.

Do not decide readiness from a number of days found online. The prescriber determines the necessary evaluation and timing. People seeking alcohol treatment also need a withdrawal and medical assessment; Vivitrol does not manage acute alcohol withdrawal. Bring a complete medication list and explain earlier withdrawal complications, liver problems, allergies, and any planned procedures so these can inform the decision.

For alcohol use disorder, define the goals of care

In alcohol treatment, the conversation should include the pattern of drinking, prior attempts to change it, medical health, and your goals. Naltrexone may be one option among several; the medication discussion should explain the expected role, alternatives, follow-up, and reasons another approach might be preferable. SAMHSA outlines naltrexone's uses in alcohol and opioid treatment.

Ask what support is available around high-risk situations, sleep, anxiety, relationships, and return to drinking. An injection does not resolve each of those concerns. If drinking changes or withdrawal symptoms develop, contact the clinical team; do not assume a medication for ongoing recovery makes withdrawal medically safe.

Opioid safety and future pain treatment need a plan

Trying to overcome naltrexone's opioid blockade by taking more opioids can cause a fatal overdose. Vulnerability also changes after treatment ends, when an injection is missed, or as its effects diminish, because opioid tolerance can be lower. Ask about access to overdose reversal medication and make sure a trusted support person knows the emergency plan.

Tell medical and dental professionals that you receive extended-release naltrexone, particularly before a procedure or emergency pain treatment. Pain care may require additional planning. Keep an accurate medication record available. Do not experiment with opioid pain medicines or treat a return to opioid use as something to manage alone. Call 911 for suspected overdose or dangerous breathing changes.

Discuss side effects before they become a barrier

Ask which effects are expected, which need a call to the prescriber, and which require urgent assessment. Injection-site reactions can occasionally be serious. New or worsening pain, swelling, skin changes, or a wound at the injection site should be reported promptly. The care team should also discuss liver-related concerns, mood changes, allergic reactions, and other relevant warnings.

Follow-up is an opportunity to review more than symptoms. Are you receiving counseling or other agreed support? Is the appointment schedule manageable? Are transportation, cost, or privacy concerns affecting attendance? If you are thinking about stopping or changing treatment, involve the prescriber so continuity and safety can be addressed.

Clarify services and costs before making arrangements

Ask whether medication assessment and injection administration are available, who prescribes, how the medicine is obtained, and what happens if an appointment needs to change. Insurance may treat the medicine and the administration service differently, so request an explanation of benefits and estimated responsibility for each. Verification is not a guarantee of payment.

Eleve's Admissions team can discuss the current substance-use and co-occurring pathway and whether the available level of care fits your needs. This educational page does not establish eligibility for Vivitrol or guarantee an injection. Bring the names of current medications and prescribers, your pharmacy and insurance details, and the questions that would help you compare treatment options.

Sources and further reading

  1. Vivitrol prescribing information, updated December 2025
  2. SAMHSA: Naltrexone
  3. DailyMed: Vivitrol patient and prescribing information
  4. SAMHSA: Opioid overdose reversal medications
Eleve

compassionate care.
clinical excellence.